Wendy Chan
Vorstandsvorsitzender bei LODE GOLD RESOURCES INC.
Vermögen: 45 920 $ am 30.04.2024
Aktive Positionen von Wendy Chan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MANDALA CAPITAL INC. | Direktor/Vorstandsmitglied | 01.05.2022 | - |
| Vorstandsvorsitzender | - | 01.05.2022 | |
| RIVERSIDE RESOURCES INC. | Direktor/Vorstandsmitglied | 01.03.2022 | - |
| Independent Dir/Board Member | 01.03.2022 | - | |
| LODE GOLD RESOURCES INC. | Direktor/Vorstandsmitglied | 11.09.2023 | - |
| Vorstandsvorsitzender | 19.12.2023 | - |
Karriereverlauf von Wendy Chan
Ehemalige bekannte Positionen von Wendy Chan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Bc Cancer Foundation | Direktor/Vorstandsmitglied | - | - |
| AURORA CANNABIS INC. | Corporate Officer/Principal | - | - |
NexGen Hearing
 NexGen Hearing Medical SpecialtiesHealth Technology NexGen Hearing provides hearing healthcare products and services. | Corporate Officer/Principal | - | - |
Janssen, Inc.
 Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Corporate Officer/Principal | - | - |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - | - |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | - | - |
| ░░░░░░░ ░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░ ░░░░░ ░░░░░░░ ░ ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░ | - | - | |
| ░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░ | - | - | |
| ░░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Wendy Chan
| University of British Columbia | Undergraduate Degree |
| McGill University | Masters Business Admin |
Statistik
International
| Kanada | 14 |
| Vereinigte Staaten | 3 |
Operativ
| Corporate Officer/Principal | 7 |
| Director/Board Member | 6 |
| Chief Executive Officer | 2 |
Sektoral
| Health Technology | 6 |
| Non-Energy Minerals | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| SKEENA RESOURCES LIMITED | Non-Energy Minerals |
| MANDALA CAPITAL INC. | Finance |
| JOHNSON & JOHNSON | Health Technology |
| AURORA CANNABIS INC. | Process Industries |
| RIVERSIDE RESOURCES INC. | Non-Energy Minerals |
| LODE GOLD RESOURCES INC. | Non-Energy Minerals |
| Private Unternehmen | 7 |
|---|---|
| Moxie Strategy, Inc. | |
| Care Point Medical & Wellness Clinics | |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
NexGen Hearing
NexGen Hearing Medical SpecialtiesHealth Technology NexGen Hearing provides hearing healthcare products and services. | Health Technology |
| Bc Cancer Foundation |
- Börse
- Insiders
- Wendy Chan
- Erfahrung
